IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity

por Kumar, S, Ingle, H, Mishra, S, Mahla, R S, Kumar, A, Kawai, T, Akira, S, Takaoka, A, Raut, A A, Kumar, H
Publicado 2015